Table 1.
Diagnoses of study population (n = 118)
| With radiological PPFE | Without radiological PPFE | |||
|---|---|---|---|---|
| Total | Definite | Consistent | ||
| Number | 30 (25.4) | 12 (10.2) | 18 (15.3) | 88 (74.6) |
| LONIPC | 12 (40.0) | 6 (50.0) | 6 (33.3) | 2 (2.3) |
| Idiopathic PPFE | 9 (30.0) | 5 (41.7) | 4 (22.2) | 0 (0.0) |
| IPF | 4 (13.3) | 0 (0.0) | 4 (22.2) | 33 (37.5) |
| Other IIPs | 2 (6.7) | 0 (0.0) | 2 (11.1) | 21 (23.9) |
| CTD-ILD | 2 (6.7) | 1 (8.3) | 1 (5.6) | 25 (28.4) |
| HP | 1 (3.3) | 0 (0.0) | 1 (5.6) | 7 (8.0) |
Data are presented as number (percentage)
Abbreviations: PPFE plueroparenchymal fibroelastosis, LONIPC late-onset non-infectious pulmonary complication after hematopoetic stem-cell transplantation and/or chemotherapy, IPF idiopathic pulmonary fibrosis, other IIPs other idiopathic interstitial pneumonias than idiopathic pulmonary fibrosis, CTD-ILD connective tissue disease-associated interstitial lung disease, HP hypersensitivity pneumonia